How Will Accountable Care Organizations Hit Drug Sales?
It’s not yet clear whether physicians will rush to form accountable care organizations (ACOs) in light of newly proposed Centers for Medicare and Medicaid Services (CMS) guidelines, which are lengthy,...
View ArticleAnother Big Run on Pharma's Bank Account
What exactly did that $80 billion deposit for health reform buy? Lots of industry CEOs traveled to the White House and shook hands with President Obama during the spring and summer of 2009, and while...
View ArticleClik here to view.
Got Ideas About Medicare and Medicaid Reform?
The Center for Medicare and Medicaid Innovation (CMMI) is now accepting applications for its Innovation Advisors Program. The CMMI, created by the Affordable Care Act, is tasked with “testing new...
View ArticleWorking Out the Kinks in Health IT
Industry executives and government officials convened in Washington DC yesterday to examine the present state of health information technology (HIT), and to identify the bugs, challenges and hiccups...
View ArticleEthics in Drug Innovation: The First Hurdle is Trust
By Ansis Helmanis Ethics is a matter of trust, which in the regulatory space requires transparency and openness among all stakeholders, including patients and industry. This was the consensus of FDA...
View ArticleQuestions About the 2013 Implementation of IPAB
by Tom Norton With the general election behind us, the anticipated avalanche of ObamaCare regulations has begun. Last week, it was reported that more than 13,000 pages of rules and regulations have...
View ArticleClik here to view.
Drug Utilization Under Managed Medicaid
Cash-strapped states are shifting patients from traditional fee-for-service Medicaid coverage to managed Medicaid plans. The IMS Institute of Healthcare Informatics took an early look at how this trend...
View ArticleYour 2014 Medicaid Sales & Marketing Plans
by Tom Norton If you are an Rx regional sales director or a product marketing manager, I have a somewhat provocative question for you: How exactly are you planning your 2014 Medicaid strategy? I ask...
View ArticleClik here to view.
CMS taps IT firm CGI for Sunshine Act Data Dump
Shantanu Agrawal, director, data sharing & partnership group, Center for Program Integrity, CMS Speaking at CBI’s Sunshine & Aggregate Spend Conference in Washington DC on Tuesday, Shantanu...
View ArticlePharma Revenues, Health Expenditures Set to Increase
Healthcare spending will rise modestly in the US over the next decade, as economic growth picks up, health reform provides expanded coverage, and the population continues to age, according to an annual...
View ArticleCo-Pay Offset Programs and Health Insurance Marketplaces: Causes for Concern
Co-Pay Offset Programs and Health Insurance Marketplaces As the health insurance marketplaces begin enrollment next week and go-live on January 1, 2014, several issues continue to be a source of...
View ArticleThe First Day of Obamacare: Is US Pharma Ready?
by Tom Norton For more than three years, the US pharmaceutical industry has known that today would arrive. So this is it. The first day that eligible U.S. citizens can sign up for Obamacare — and enjoy...
View ArticleCo-Pay Offset Programs and the New Health Insurance Marketplace: Will the...
By Mark McAndrew. As the health insurance marketplaces begin enrollment this week and go live on January 1, 2014, several issues continue to be a source of significant confusion to manufacturers,...
View ArticleClik here to view.
Putting a Price Tag on Compliance: Cheap Change or Big Bucks?
John Kamp, Executive Director, Coalition for Healthcare Communication Compliance rules under the US Physician Payments Sunshine Act have been criticized for the excruciating level of detail demanded...
View ArticleDrug Reimbursement: Make Room at the Table for Patients and Researchers
At last week’s Partnering for Cures conference held in New York City, several expert panels discussed new angles of approaching solutions to disease, encouraging investment and mitigating...
View ArticleConfessions of a Compliance Director
In anticipation of CBI’s (a PharmExec sibling company) 11th Annual Pharma Compliance Congress happening later this month, PharmExec spoke with a compliance director at a mid-sized pharma ($5 billion in...
View ArticleObama Administration Halts Attack on Medicare Drug Plans
In an abrupt about-face, the Obama administration halted its ill-timed effort to launch an overhaul of the Medicare Part D program and announced it would not pursue changes in some key rules as...
View ArticleMedicare Payment Data Raises Questions About Drug Costs
Even though the just-released Medicare data on payments to individual doctors doesn’t provide specifics on prescription drug outlays, it opens the door to sharp scrutiny of Medicare reimbursement for...
View Article
